Literature DB >> 25991649

Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model.

Roberto Visentin1, Chiara Dalla Man1, Rita Basu2, Ananda Basu2, Robert A Rizza2, Claudio Cobelli3.   

Abstract

Recently, a model was proposed to assess hepatic insulin sensitivity during a meal, i.e., the ability of insulin to suppress glucose production (EGP), SI (P). The model was developed on EGP data obtained from a triple-tracer meal and the tracer-to-tracee clamp technique and validated against the euglycemic hyperinsulinemic clamp. The aim of this study was to assess whether SI (P) can be obtained from plasma concentrations measured after a single-tracer meal by incorporating the above EGP model into the oral glucose minimal model by describing both glucose production and disposal (OMM(PD)). Triple-tracer meal data of two databases (20 healthy and 60 healthy and prediabetic subjects) were used. Virtually model-independent EGP estimates were calculated. OMM(PD) was identified on exogenous and endogenous glucose concentrations, providing indices of SI (P), disposal insulin sensitivity (SI (D)), and EGP. The model fitted the data well, and SI (P) and SI (D) were estimated with precision in both databases (SI (P) = 5.48 ± 0.54 10(-4) dl·kg(-1)·min(-1) per μU/ml and SI (D) = 9.93 ± 2.18 10(-4) dl·kg(-1)·min(-1) per μU/ml in healthy; SI (P) = 5.41 ± 3.55 10(-4) dl·kg(-1)·min(-1) per μU/ml and SI (D) = 5.34 ± 6.17 10(-4) dl·kg(-1)·min(-1) per μU/ml, in healthy and prediabetic subjects). Estimated SI (P) and that derived from the triple-tracer EGP model were very similar on average. Moreover, the time course of EGP normalized to basal EGP (EGPb), and EGP/EGPb agreed with the results obtained using the triple-tracer method. In this study, we have demonstrated that SI (P), SI (D), and EGP/EGPb time course can be estimated reliably from a single-tracer meal protocol in both healthy and prediabetic subjects.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  glucose kinetics; insulin resistance; meal; tracer

Mesh:

Substances:

Year:  2015        PMID: 25991649      PMCID: PMC4504934          DOI: 10.1152/ajpendo.00358.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

1.  Undermodeling affects minimal model indexes: insights from a two-compartment model.

Authors:  A Caumo; P Vicini; J J Zachwieja; A Avogaro; K Yarasheski; D M Bier; C Cobelli
Journal:  Am J Physiol       Date:  1999-06

2.  Use of a novel triple-tracer approach to assess postprandial glucose metabolism.

Authors:  Rita Basu; Barbara Di Camillo; Gianna Toffolo; Ananda Basu; Pankaj Shah; Adrian Vella; Robert Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-01       Impact factor: 4.310

3.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.

Authors:  Chiara Dalla Man; Marco Campioni; Kenneth S Polonsky; Rita Basu; Robert A Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

4.  Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model.

Authors:  Chiara Dalla Man; Andrea Caumo; Rita Basu; Robert Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-21       Impact factor: 4.310

5.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

Authors:  P H Barrett; B M Bell; C Cobelli; H Golde; A Schumitzky; P Vicini; D M Foster
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

6.  Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.

Authors:  Rita Basu; Chiara Dalla Man; Marco Campioni; Ananda Basu; George Klee; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

7.  Insulin sensitivity by oral glucose minimal models: validation against clamp.

Authors:  Chiara Dalla Man; Kevin E Yarasheski; Andrea Caumo; Heather Robertson; Gianna Toffolo; Kenneth S Polonsky; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-07-12       Impact factor: 4.310

8.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.

Authors:  R G Firth; P M Bell; H M Marsh; I Hansen; R A Rizza
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

9.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

Review 10.  The oral minimal model method.

Authors:  Claudio Cobelli; Chiara Dalla Man; Gianna Toffolo; Rita Basu; Adrian Vella; Robert Rizza
Journal:  Diabetes       Date:  2014-04       Impact factor: 9.461

View more
  9 in total

1.  A simple method to monitor hepatic gluconeogenesis and triglyceride synthesis following oral sugar tolerance test in obese adolescents.

Authors:  Anne-Marie Carreau; Eunsook S Jin; Yesenia Garcia-Reyes; Haseeb Rahat; Kristen J Nadeau; Craig R Malloy; Melanie Cree-Green
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-01       Impact factor: 3.619

2.  Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes.

Authors:  Isabel Errazuriz; Simmi Dube; Michael Slama; Roberto Visentin; Sunita Nayar; Helen O'Connor; Claudio Cobelli; Swapan Kumar Das; Ananda Basu; Walter Karl Kremers; John Port; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

3.  Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.

Authors:  Ling Hinshaw; Michele Schiavon; Vikash Dadlani; Ashwini Mallad; Chiara Dalla Man; Adil Bharucha; Rita Basu; Jennifer R Geske; Rickey E Carter; Claudio Cobelli; Ananda Basu; Yogish C Kudva
Journal:  J Clin Endocrinol Metab       Date:  2016-03-01       Impact factor: 5.958

4.  Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials.

Authors:  Claudio Cobelli; Chiara Dalla Man
Journal:  J Diabetes Sci Technol       Date:  2021-05-25

5.  Good agreement between hyperinsulinemic-euglycemic clamp and 2 hours oral minimal model assessed insulin sensitivity in adolescents.

Authors:  Anne-Marie Carreau; Danielle Xie; Yesenia Garcia-Reyes; Haseeb Rahat; Kai Bartlette; Cecilia Diniz Behn; Laura Pyle; Kristen J Nadeau; Melanie Cree-Green
Journal:  Pediatr Diabetes       Date:  2020-07-31       Impact factor: 3.409

6.  A New Oral Model to Assess Postprandial Lactate Production Rate.

Authors:  Jacopo Bonet; Brittany Galuppo; Nicola Santoro; Chiara DallaMan
Journal:  IEEE Trans Biomed Eng       Date:  2022-03-18       Impact factor: 4.756

7.  A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy.

Authors:  Luca Marchetti; Federico Reali; Marco Dauriz; Corinna Brangani; Linda Boselli; Giulia Ceradini; Enzo Bonora; Riccardo C Bonadonna; Corrado Priami
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

8.  Dynamical compensation in physiological circuits.

Authors:  Omer Karin; Avital Swisa; Benjamin Glaser; Yuval Dor; Uri Alon
Journal:  Mol Syst Biol       Date:  2016-11-08       Impact factor: 11.429

9.  Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids.

Authors:  Steven Hamley; Danielle Kloosterman; Tamara Duthie; Chiara Dalla Man; Roberto Visentin; Shaun A Mason; Teddy Ang; Ahrathy Selathurai; Gunveen Kaur; Maria G Morales-Scholz; Kirsten F Howlett; Greg M Kowalski; Christopher S Shaw; Clinton R Bruce
Journal:  Diabetologia       Date:  2019-09-06       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.